8-K//Current report
Viracta Therapeutics, Inc. 8-K
Accession 0000950170-24-130294
$VIRXCIK 0001061027operating
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 5:20 PM ET
Size
151.0 KB
Accession
0000950170-24-130294
Documents
- 8-Kvirx-20241121.htmPrimary
8-K
- EX-101.SCHvirx-20241121.xsd
XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
- XMLR1.htm
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0000950170-24-130294-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLvirx-20241121_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Viracta Therapeutics, Inc.
CIK 0001061027
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001061027
Filing Metadata
- Form type
- 8-K
- Filed
- Nov 21, 7:00 PM ET
- Accepted
- Nov 22, 5:20 PM ET
- Size
- 151.0 KB